TCM BIOTECH INTERNATIONAL CORP.

TCM Biotech focuses on the R&D and manufacturing of new drugs and heath food in all-round liver disease prevention, detection and treatment, including CatCHimera liver cancer gene detection platform, PTX-9908 liver cancer target drug development and liver cancer immunotherapy. At present, the company has obtained a number of invention patents for a new dietary supplement for the treatment of hepatitis B, non-alcoholic fatty liver disease and liver fibrosis, and a patent for liver cancer detection technology, so as to complete the patent layout of new drug development in the field of liver diseases. TCM Biotech will build itself into an international biotechnology company engaged in the research, production and sales of new drugs and dietary supplements for the prevention and treatment of liver diseases.